HPV Types

Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection, affecting millions of individuals in the United States. It is primarily transmitted through skin-to-skin sexual contact. While many people with HPV may not experience symptoms, the virus can lead to complications such as genital warts. These warts can vary in size, appearance, and location, often appearing on the vulva in women and the penis in men. Additionally, some HPV infections can persist in the body and increase the risk of developing certain types of cancer.

HPV is responsible for:

• 25% of vulvar cancers
• 50% of penile cancers
• 60% of oropharyngeal cancers
• 78% of vaginal cancers
• 90% of anal cancers
• Almost all cases of genital warts and cervical cancer

Browse all our HPV products

Figure 1. Natural history of oncogenic HPV infection.
(Source: Della Fera, A. N. et al., 2021)

Low-Risk HPV

Low-risk HPV types are primarily associated with the development of benign conditions, such as genital warts, which can appear on various areas of the body such as the vulva, penis, cervix, vagina, scrotum, anus, mouth, and throat. Genital warts are primarily caused by two HPV strains, types 6 and 11, which account for approximately 90% of cases. Only a small percentage (~1%) of sexually active individuals in the United States experience noticeable genital warts. It is important to treat these warts to prevent their spread to other genital areas and sexual partners. In addition, some strains can cause mild cervical dysplasia, which refers to abnormal changes in the surface cells of the cervix.

Although low-risk types do not typically lead to cancer, they can still cause physical discomfort and psychological distress. Proper diagnosis and management of low-risk HPV infections are crucial to alleviate symptoms and prevent transmission.

Creative Diagnostics: Your Reliable Partners

HPV typing is a crucial component of HPV-related disease management, prevention, and research. The identification and classification of HPV types enable targeted interventions, such as vaccination and screening programs, to reduce the burden of HPV-related cancers and other conditions. Creative Diagnostics, a trusted company in the field, offers advanced HPV typing solutions that empower healthcare professionals in their efforts to combat HPV. By leveraging our innovative assays and products, clinicians and researchers can make informed decisions, improve patient outcomes, and contribute to the global fight against HPV-related diseases.